Women on 'skinny jabs' must use effective contraception, MHRA urges in latest guidance
Credits: Kate Wadia founder & CCO Daniel Wadia founder & CSO David Zoppi Senior Art Director & Design Joe Maruca: Senior Designer Sean Serafini, Designer Diego Salinas, Motion Designer Production House: Bindery Photographer & Director: Cameron McNee Source: Mrs&Mr
In the world of weight loss and obesity treatment, a new medication has emerged that is making waves: tirzepatide
The main challenge during the initial development of GLP-1 receptor agonists was the very short half-life in the circulation of 2 minutes [34]
Patients at higher risk include: Those on higher doses : Tirzepatide is available in escalating doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg)
Dietary supplements should not be used as a substitute for a varied diet